CUMYL-PICA
http://dbpedia.org/resource/CUMYL-PICA an entity of type: Thing
CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006. It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers. CUMYL-PICA acts as an agonist for the cannabinoid receptors, with Ki values of 59.21 nM at CB1 and 136.38 nM at CB2 and EC50 values of 11.98 nM at CB1 and 16.2 nM at CB2.
rdf:langString
rdf:langString
CUMYL-PICA
xsd:integer
47188612
xsd:integer
1093419671
xsd:integer
23
xsd:integer
1400742
xsd:integer
34450887
xsd:integer
28
xsd:integer
1
rdf:langString
NpSG
rdf:langString
Class B
xsd:integer
2
xsd:integer
1
xsd:integer
86273678
rdf:langString
O=CC2=CNC3=C2C=CC=C3
xsd:integer
1
rdf:langString
RCXFMWJQOYCIQU-UHFFFAOYSA-N
rdf:langString
H4APZ90T9U
rdf:langString
CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006. It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers. CUMYL-PICA acts as an agonist for the cannabinoid receptors, with Ki values of 59.21 nM at CB1 and 136.38 nM at CB2 and EC50 values of 11.98 nM at CB1 and 16.2 nM at CB2.
rdf:langString
Schedule II
xsd:nonNegativeInteger
4103
xsd:string
1400742-32-6
xsd:string
H4APZ90T9U
xsd:string
86273678